The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.
about
IL1R2, CCR2, and CXCR4 May Form Heteroreceptor Complexes with NMDAR and D2R: Relevance for Schizophrenia.Autism Spectrum Disorders and Schizophrenia Spectrum Disorders: Excitation/Inhibition Imbalance and Developmental Trajectories.The Emerging Role for Zinc in Depression and Psychosis.Toxoplasma gondii-A Gastrointestinal Pathogen Associated with Human Brain Diseases.Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and DiseaseEfficacy of Memantine in Schizophrenic Patients: A Systematic Review.Diverse Effects on M1 Signaling and Adverse Effect Liability within a Series of M1 Ago-PAMs.Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation.Altered CREB Binding to Activity-Dependent Genes in Serine Racemase Deficient Mice, a Mouse Model of Schizophrenia.Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1 PAM VU6004256.The effects of nicotine in the neonatal quinpirole rodent model of psychosis: Neural plasticity mechanisms and nicotinic receptor changes.Immediate Early Genes Anchor a Biological Pathway of Proteins Required for Memory Formation, Long-Term Depression and Risk for Schizophrenia.Autoimmune phenotypes in schizophrenia reveal novel treatment targets.Identification of expression quantitative trait loci associated with schizophrenia and affective disorders in normal brain tissueThe Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and ReviewAstrocytic Regulation of Glutamate Transmission in Schizophrenia
P2860
Q33364911-44C62291-EFD9-408E-94F9-10BD5D2DB84CQ33619607-CF7D6B74-852D-4285-AD88-BAB07CA1CF8BQ33857369-7B39A381-2707-4832-847D-58DE234D2E7EQ33901336-FB01B0C8-22DC-4848-A02F-5248633B3907Q36300230-553B02CE-656D-4B9C-8156-BA637160F596Q37627540-3D482302-D805-48EF-B537-D0ADEE05C457Q39077987-B99A98F7-40C4-4456-A8CD-2C73CE290A23Q41502069-F2085A2D-BF91-4615-975F-7FB4354EC4E4Q47367883-75067CF5-BDF9-42A6-BD90-7137AF9ED899Q47393629-3F28664A-A9BF-4A73-9992-CF1D5FC64E2EQ47848449-00AB0B90-E134-4F91-9810-94C5390A5B70Q50531661-C50BC695-D148-4384-A5E4-6A79DE603E30Q54217096-7C730D2C-95DC-47F2-8F30-F19894A0035FQ57677495-ABCF2DA6-B225-4C56-A1E0-BE86E900EE54Q58122198-B3713026-9CE1-4F71-A048-75E8B3542063Q59128381-5CCFE91F-A6D3-4460-BEEF-2760C23A060C
P2860
The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.
@ast
The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.
@en
type
label
The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.
@ast
The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.
@en
prefLabel
The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.
@ast
The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.
@en
P2860
P1476
The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.
@en
P2093
P2860
P304
P356
10.1016/BS.APHA.2016.01.006
P577
2016-03-04T00:00:00Z